CoAxia

CoAxia is a development stage, private, venture-backed medical device company in clinical trials with NeuroFlo, an innovative, catheter-based therapy for the treatment of cerebral ischemia.

CoAxia is in limited distribution of NeuroFlo to treat cerebral vasospasm, under an HDE market approval from the FDA.

CoAxia holds several key patents on the concept and implementation of cerebral perfusion augmentation as well as numerous other patents relevant to various vascular disorders.